USANA HEALTH SCIENCES INC (USNA) Fundamental Analysis & Valuation

NYSE:USNA • US90328M1071

Current stock price

19.44 USD
+0.2 (+1.04%)
At close:
19.44 USD
0 (0%)
After Hours:

This USNA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. USNA Profitability Analysis

1.1 Basic Checks

  • USNA had positive earnings in the past year.
  • In the past year USNA had a positive cash flow from operations.
  • USNA had positive earnings in each of the past 5 years.
  • USNA had a positive operating cash flow in each of the past 5 years.
USNA Yearly Net Income VS EBIT VS OCF VS FCFUSNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.45%, USNA is in line with its industry, outperforming 59.46% of the companies in the same industry.
  • USNA has a Return On Equity of 2.02%. This is in the better half of the industry: USNA outperforms 64.86% of its industry peers.
  • USNA's Return On Invested Capital of 6.54% is fine compared to the rest of the industry. USNA outperforms 64.86% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for USNA is in line with the industry average of 10.52%.
Industry RankSector Rank
ROA 1.45%
ROE 2.02%
ROIC 6.54%
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
USNA Yearly ROA, ROE, ROICUSNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.16%, USNA is in line with its industry, outperforming 59.46% of the companies in the same industry.
  • USNA's Profit Margin has declined in the last couple of years.
  • USNA has a Operating Margin of 5.50%. This is in the better half of the industry: USNA outperforms 62.16% of its industry peers.
  • USNA's Operating Margin has declined in the last couple of years.
  • USNA's Gross Margin of 78.29% is amongst the best of the industry. USNA outperforms 94.59% of its industry peers.
  • USNA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.5%
PM (TTM) 1.16%
GM 78.29%
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
USNA Yearly Profit, Operating, Gross MarginsUSNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. USNA Health Analysis

2.1 Basic Checks

  • USNA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, USNA has less shares outstanding
  • Compared to 5 years ago, USNA has less shares outstanding
  • The debt/assets ratio for USNA has been reduced compared to a year ago.
USNA Yearly Shares OutstandingUSNA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
USNA Yearly Total Debt VS Total AssetsUSNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 3.63 indicates that USNA is not in any danger for bankruptcy at the moment.
  • USNA has a Altman-Z score of 3.63. This is in the better half of the industry: USNA outperforms 78.38% of its industry peers.
  • USNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.64
Altman-Z 3.63
ROIC/WACC0.76
WACC8.65%
USNA Yearly LT Debt VS Equity VS FCFUSNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 2.24 indicates that USNA has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.24, USNA is in the better half of the industry, outperforming 67.57% of the companies in the same industry.
  • A Quick Ratio of 1.45 indicates that USNA should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.45, USNA is doing good in the industry, outperforming 67.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 1.45
USNA Yearly Current Assets VS Current LiabilitesUSNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. USNA Growth Analysis

3.1 Past

  • USNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.15%.
  • USNA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.00% yearly.
  • USNA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.28%.
  • Measured over the past years, USNA shows a decrease in Revenue. The Revenue has been decreasing by -4.00% on average per year.
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.31% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, USNA will show a small growth in Revenue. The Revenue will grow by 4.02% on average per year.
EPS Next Y6.25%
EPS Next 2Y21.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.88%
Revenue Next 2Y4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USNA Yearly Revenue VS EstimatesUSNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
USNA Yearly EPS VS EstimatesUSNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. USNA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.13 indicates a reasonable valuation of USNA.
  • Compared to the rest of the industry, the Price/Earnings ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 86.49% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of USNA to the average of the S&P500 Index (27.42), we can say USNA is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 9.53, the valuation of USNA can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, USNA is valued cheaply inside the industry as 81.08% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.29, USNA is valued rather cheaply.
Industry RankSector Rank
PE 10.13
Fwd PE 9.53
USNA Price Earnings VS Forward Price EarningsUSNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, USNA is valued cheaply inside the industry as 97.30% of the companies are valued more expensively.
  • USNA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 42.09
EV/EBITDA 2.57
USNA Per share dataUSNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • USNA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of USNA may justify a higher PE ratio.
  • USNA's earnings are expected to grow with 21.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.62
PEG (5Y)N/A
EPS Next 2Y21.31%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. USNA Dividend Analysis

5.1 Amount

  • No dividends for USNA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

USNA Fundamentals: All Metrics, Ratios and Statistics

USANA HEALTH SCIENCES INC

NYSE:USNA (4/24/2026, 8:12:43 PM)

After market: 19.44 0 (0%)

19.44

+0.2 (+1.04%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-17
Earnings (Next)05-05
Inst Owners57.94%
Inst Owner Change-0.61%
Ins Owners0.74%
Ins Owner Change0.5%
Market Cap358.86M
Revenue(TTM)925.26M
Net Income(TTM)10.76M
Analysts43.33
Price Target39.78 (104.63%)
Short Float %4.89%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.91%
Min EPS beat(2)-131.29%
Max EPS beat(2)43.47%
EPS beat(4)3
Avg EPS beat(4)-12.81%
Min EPS beat(4)-131.29%
Max EPS beat(4)43.47%
EPS beat(8)6
Avg EPS beat(8)-0.77%
EPS beat(12)9
Avg EPS beat(12)8.1%
EPS beat(16)10
Avg EPS beat(16)9.49%
Revenue beat(2)0
Avg Revenue beat(2)-4.12%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)-1.86%
Revenue beat(4)2
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)3
Avg Revenue beat(8)-2.04%
Revenue beat(12)6
Avg Revenue beat(12)-1.41%
Revenue beat(16)8
Avg Revenue beat(16)-1.06%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10%
EPS NY rev (1m)0%
EPS NY rev (3m)2.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.56%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-1.44%
Valuation
Industry RankSector Rank
PE 10.13
Fwd PE 9.53
P/S 0.39
P/FCF 42.09
P/OCF 16.06
P/B 0.67
P/tB 1.37
EV/EBITDA 2.57
EPS(TTM)1.92
EY9.88%
EPS(NY)2.04
Fwd EY10.49%
FCF(TTM)0.46
FCFY2.38%
OCF(TTM)1.21
OCFY6.23%
SpS50.12
BVpS28.88
TBVpS14.19
PEG (NY)1.62
PEG (5Y)N/A
Graham Number35.3209 (81.69%)
Profitability
Industry RankSector Rank
ROA 1.45%
ROE 2.02%
ROCE 8.28%
ROIC 6.54%
ROICexc 8.81%
ROICexgc 21.74%
OM 5.5%
PM (TTM) 1.16%
GM 78.29%
FCFM 0.92%
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
ROICexc(3y)20.39%
ROICexc(5y)37.76%
ROICexgc(3y)38.56%
ROICexgc(5y)58.83%
ROCE(3y)12.43%
ROCE(5y)20.38%
ROICexgc growth 3Y-33.6%
ROICexgc growth 5Y-29.38%
ROICexc growth 3Y-44.57%
ROICexc growth 5Y-36.69%
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
F-Score7
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.64
Debt/EBITDA 0
Cap/Depr 42.45%
Cap/Sales 1.49%
Interest Coverage 76.71
Cash Conversion 26.79%
Profit Quality 79.24%
Current Ratio 2.24
Quick Ratio 1.45
Altman-Z 3.63
F-Score7
WACC8.65%
ROIC/WACC0.76
Cap/Depr(3y)541.47%
Cap/Depr(5y)369.8%
Cap/Sales(3y)9.35%
Cap/Sales(5y)6.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
EPS Next Y6.25%
EPS Next 2Y21.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%
Revenue Next Year1.88%
Revenue Next 2Y4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.31%
EBIT growth 3Y-22.1%
EBIT growth 5Y-22.03%
EBIT Next Year31.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y105.59%
FCF growth 3Y-53.9%
FCF growth 5Y-43.29%
OCF growth 1Y-63.36%
OCF growth 3Y-40.08%
OCF growth 5Y-32.58%

USANA HEALTH SCIENCES INC / USNA Fundamental Analysis FAQ

What is the fundamental rating for USNA stock?

ChartMill assigns a fundamental rating of 6 / 10 to USNA.


Can you provide the valuation status for USANA HEALTH SCIENCES INC?

ChartMill assigns a valuation rating of 7 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Undervalued.


What is the profitability of USNA stock?

USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for USNA stock?

The Price/Earnings (PE) ratio for USANA HEALTH SCIENCES INC (USNA) is 10.13 and the Price/Book (PB) ratio is 0.67.


What is the expected EPS growth for USANA HEALTH SCIENCES INC (USNA) stock?

The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to grow by 6.25% in the next year.